Head and Neck Cancer Therapeutics Market by Therapy Type (Immunotherapy, Chemotherapy, Radiation Therapy), Route of Administration (Oral, Injectable), Distribution Channel (Online Pharmacies, Retail & Specialty Pharmacies), and by Region - Global Forecast to 2022-2033

The head and neck cancer therapeutics market size is estimated to be USD 1,589.5 million in 2022 and is expected to witness a CAGR of 12.78% during the forecast period 2023-2033. Rising head and neck cancer rates, rise in the world’s geriatric population, use of tobacco and alcohol, awareness of medical advancements and treatments are some of the factors contributing to the market growth. Furthermore, existence of a robust product pipeline and its planned launch and acceptance of immunotherapy in some nations are other factors supporting the market growth. However, negative effects of long-term usage of such medicines are expected to hinder the growth.

Rising head and neck cancer rates is predicted to spur the market growth during the projected period. About 4% of all cancer cases in the United States, according to the American Society of Clinical Oncology (ASCO), involve the head and neck. In 2022, it is anticipated that 66,470 people, 48,520 men, and 17,950 women, will have this condition.

Existence of a robust product pipeline and its planned launch is expected to propel the market growth during the forecast period. Tipifarnib (a farnesyltransferase inhibitor), tiragolumab (an anti-TIGIT), Tecentriq (atezolizumab), Rozlytrek (entrectinib), and Afatinib are a few of the products in development. Over the course of the projection period, market growth is predicted to be driven by successful trial outcomes and subsequent approval. Tipifarnib, developed by Kura Oncology, Inc., was given breakthrough therapy designation by the US FDA in February 2021 for the treatment of patients with head and neck squamous cell carcinoma (HNSCC).

Segmentation

By Therapy Type

The market is categorized into immunotherapy, chemotherapy, radiation therapy, and targeted therapy. In 2022, the immunotherapy segment accounted for the highest revenue share due to the approval of novel immunotherapy medications. According to the Cancer Research Institute, Nivolumab (Opdivo) and Pembrolizumab (Keytruda) are the two PD-L1 inhibitors that are currently licenced for the treatment of individuals with head and neck cancer. Dostarlimab (Jemperli) is undergoing Phase II clinical studies for head and neck squamous cell carcinoma that has spread or recur. In 2022, targeted therapy emerged as the second-largest revenue-generating sector. This can be due to the encouraging and successful outcomes related to the use of targeted therapy as a therapeutic choice for people with head and neck cancer. Tyrosine kinase inhibitors and EGFR monoclonal antibodies (nimotuzumab, panitumumab, cetuximab, and zalutumumab) are used in this treatment (erlotinib, Gefitinib, dacomitinib, afatinib, lapatinib).

By Route of Administration

The market is categorized into oral and injectable. In the global market, the injectable segment accounted for the largest revenue share in 2022 owing to widespread accessibility of many HNC therapeutic drugs in injectable form, improved availability, and high efficacy of injectable treatments. Injectable forms of several drugs are readily available. For instance, patients with head and neck cancer receive an intravenous infusion of the Merck & Co., Inc. drug Keytruda. The oral route of administration is anticipated to rise at the quickest rate over the projection period due to growing number of oral therapeutic medications used to treat patients with HNC. A phase 2 clinical trial for the oral HNC drug Inlyta (axitinib) in patients with head and neck cancer has been successfully completed.

By Distribution Channel

The market is segmented into online pharmacies, retail & specialty pharmacies, and hospital pharmacies. In 2022, the retail & specialty pharmacies segment accounted for the largest revenue share owing to manufacturers’ strong demand for distributing their products due to simple access to medications and inexpensive delivery costs. The top five specialty pharmacies in the globe in 2021, according to the Drug Channels Institute’s research, were Humana specialty pharmacy, Accredo, CVS Specialty, Walgreens stores, and Optum specialty pharmacy. Additionally, over the course of the forecast period, the retail and specialty pharmacies segment is also anticipated to increase at the fastest rate. This is attributed to the simple accessibility of a variety of products. Moreover, the expansion of retail pharmacies in both developed and developing nations has contributed to the segment’s rapid growth. HNC products are generally accessible in both retail and specialty pharmacies. The segment is anticipated to grow as a result of this.

Regional Markets

In 2022, North America region accounted for the highest revenue in the head and neck cancer therapeutics market and is expected to maintain its dominance during the forecast period. This is attributed to the government assistance for the expansion of the healthcare industry, favourable reimbursement rules, increasing disease awareness, and simple access to high-quality healthcare facilities. The head and neck cancer therapeutics market in Asia Pacific is predicted to expand at the fastest rate during the forecast period. In the next years, market growth is anticipated to be driven by the growing elderly population and the rising use of immunotherapy medicines including Pembrolizumab (Keytruda) and Nivolumab (Opdivo) for the treatment of various forms of HNC.

Competitor Insights

Some of the key players operating in the head and neck cancer therapeutics market are Merck & Co., Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, AstraZeneca, Takeda Pharmaceutical Company Limited, Sanofi, Clinigen Group plc., Teva Pharmaceutical Industries Ltd, and F. Hoffmann-La Roche Ltd.

To achieve a competitive edge, these companies are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

  • For instance, Sanofi spent USD 1 billion to acquire Amunix Pharmaceuticals, Inc. in December 2021. This acquisition broadens the company’s line of oncology products and presents a significant opportunity for the business to grow.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including therapy type, route of administration, and distribution channel from 2023 to 2033.

Report Scope:

Key Parameters Details
Market size in 2022
  • USD 1,589.5 Million
CAGR
  • 12.78%
Base Year
  • 2022
Forecast Period
  • 2023-2033
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • COVID-19 impact analysis
Segment Market Scope
  • Therapy Type
  • Route of Administration
  • Distribution Channel
Regional Market Scope
  • North America
    (U.S. and Canada)
  • Europe
    (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific
    (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America
    (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA
    (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 10 players
  • Other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Segmentation: Head and Neck Cancer Therapeutics Market Report 2022 – 2033

Therapy Type (Revenue, USD Million), 2022 – 2033

  • Immunotherapy
  • Chemotherapy
  • Radiation Therapy
  • Targeted Therapy

Route of Administration (Revenue, USD Million), 2022 – 2033

  • Oral
  • Injectable

Distribution Channel (Revenue, USD Million), 2022 – 2033

  • Online Pharmacies
  • Retail & Specialty Pharmacies
  • Hospital Pharmacies

By Region (Revenue, USD Million), 2022 – 2033

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Table of Contents: Head and Neck Cancer Therapeutics Market 2022-2033

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
  1. Introduction: Head and Neck Cancer Therapeutics
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. SWOT Analysis
  2. COVID-19 Impact Analysis: Head and Neck Cancer Therapeutics Market
  3. Market Analysis by Therapy Type
    1. Immunotherapy
      1. Immunotherapy Market Forecast, 2022-2033(USD Million)
    2. Chemotherapy
      1. Chemotherapy Market Forecast, 2022-2033(USD Million)
    3. Radiation Therapy
      1. Radiation Therapy Market Forecast, 2022-2033(USD Million)
    4. Targeted Therapy
      1. Targeted Therapy Market Forecast, 2022-2033(USD Million)
  1. Market Analysis by Route of Administration
    1. Oral
      1. Oral Market Forecast, 2022-2033(USD Million)
    2. Injectable
      1. Injectable Market Forecast, 2022-2033(USD Million)
  1. Market Analysis by Distribution Channel
    1. Online Pharmacies
      1. Online Pharmacies Market Forecast, 2022-2033(USD Million)
    2. Retail & Specialty Pharmacies
      1. Retail & Specialty Pharmacies Market Forecast, 2022-2033(USD Million)
    3. Hospital Pharmacies
      1. Hospital Pharmacies Market Forecast, 2022-2033(USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends Analysis
  2. North America Head and Neck Cancer Therapeutics Market
    1. North America Head and Neck Cancer Therapeutics Market
      1. North America Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
        2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
        3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
      2. S. Head and Neck Cancer Therapeutics Market
        1. S. Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
          2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
          3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
        2. Canada Head and Neck Cancer Therapeutics Market
          1. Canada Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
            2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
            3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
  1. Europe Head and Neck Cancer Therapeutics Market
    1. Europe Head and Neck Cancer Therapeutics Market
      1. Europe Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
        2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
        3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
      2. Germany Head and Neck Cancer Therapeutics Market
        1. Germany Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
          2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
          3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
        2. UK Head and Neck Cancer Therapeutics Market
          1. UK Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
            2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
            3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
          2. France Head and Neck Cancer Therapeutics Market
            1. France Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
              2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
              3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
            2. Spain Head and Neck Cancer Therapeutics Market
              1. Spain Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
                2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
                3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
              2. Italy Head and Neck Cancer Therapeutics Market
                1. Italy Market Size and Forecast, 2022-2033(USD Million)
                  1. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
                  2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
                  3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
                2. Rest of Europe Head and Neck Cancer Therapeutics Market
                  1. Rest of Europe Market Size and Forecast, 2022-2033(USD Million)
                    1. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
                    2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
                    3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
  1. Asia Pacific Head and Neck Cancer Therapeutics Market
    1. Asia Pacific Head and Neck Cancer Therapeutics Market
      1. Asia Pacific Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
        2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
        3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
      2. Japan Head and Neck Cancer Therapeutics Market
        1. Japan Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
          2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
          3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
        2. China Head and Neck Cancer Therapeutics Market
          1. China Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
            2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
            3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
          2. India Head and Neck Cancer Therapeutics Market
            1. India Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
              2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
              3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
            2. South Korea Head and Neck Cancer Therapeutics Market
              1. South Korea Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
                2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
                3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
              2. Australia Head and Neck Cancer Therapeutics Market
                1. Australia Market Size and Forecast, 2022-2033(USD Million)
                  1. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
                  2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
                  3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
                2. Rest of Asia Pacific Head and Neck Cancer Therapeutics Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2022-2033(USD Million)
                    1. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
                    2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
                    3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
  1. Latin America Head and Neck Cancer Therapeutics Market
    1. Latin America Head and Neck Cancer Therapeutics Market
      1. Latin America Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
        2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
        3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
      2. Brazil Head and Neck Cancer Therapeutics Market
        1. Brazil Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
          2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
          3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
        2. Mexico Head and Neck Cancer Therapeutics Market
          1. Mexico Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
            2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
            3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
          2. Argentina Head and Neck Cancer Therapeutics Market
            1. Argentina Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
              2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
              3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
            2. Rest of Latin America Head and Neck Cancer Therapeutics Market
              1. Rest of Latin America Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
                2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
                3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
  1. MEA Head and Neck Cancer Therapeutics Market
    1. MEA Head and Neck Cancer Therapeutics Market
      1. MEA Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
        2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
        3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
      2. GCC Head and Neck Cancer Therapeutics Market
        1. GCC Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
          2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
          3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
        2. South Africa Head and Neck Cancer Therapeutics Market
          1. South Africa Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
            2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
            3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
          2. Rest of MEA Head and Neck Cancer Therapeutics Market
            1. Rest of MEA Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
              2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
              3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2022
    2. Major Recent Developments, 2019-2022
  2. Company Profiles
    1. Merck & Co., Inc.
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    2. Eli Lilly and Company
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    3. Bristol-Myers Squibb Company
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    4. AstraZeneca
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    5. Takeda Pharmaceutical Company Limited
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    6. Sanofi
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    7. Clinigen Group plc.
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    8. Teva Pharmaceutical Industries Ltd
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    9. Hoffmann-La Roche Ltd.
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    10. Company 10
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    11. Company 11
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    12. Company 12
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    13. Company 13
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
  1. Conclusion
  2. Recommendations

Leave a comment

Your email address will not be published. Required fields are marked *

Select License Type

5 reasons to choose Quintana Research Reports

Our top-quality, real-time, accurate, and data-driven research aims at empowering the clients with actionable insights.

We deliver timely data-driven insights to help clients make informed decisions and achieve growth and success.

Our team of experts is available 24*7 to offer incisive analysis of the market for clients.

We offer comprehensive and bespoke marketing research as per clients’ requirements.

Our cost-effective and rapid research helps clients gain competitive intelligence, and uncover potential opportunities & threats.